BioSpace News Archive

Coronavirus nCOV-2019 antigenic epitopes predicted by EpiVax computational vaccinology and epitope prediction tools to be linked with Ii-Key to generate peptide vaccines against COVID-19

MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that the Datacise Integrated Safety Explorer will make its debut at the 2020 PHUSE U.S. Connect conference in Orlando, Florida as part of the PHUSE/FDA Data Science Innovation Challenge, where, according to PHUSE, the “greatest minds in the data sciences arena come together and collaborate.”

Evolus, Inc. (NASDAQ: EOLS) today provided the following statement: “In several media reports this week, Medytox has made comments on the International Trade Commission (ITC) case, which Evolus believes are speculative and intended to create confusion in the U.S. market ahead of the ITC Judge’s initial determination in June 2020 and the ITC’s final determination, which is targeted for October 2020.

Devices Found to Present Unreasonable and Substantial Risk of Illness or Injury

Cigna Corporation (NYSE: CI) announced today that it has commenced tender offers to purchase for cash (1) up to $500,000,000 (the " 2022 Notes Aggregate Maximum Principal Amount ") of Cigna Holding Company’s 4.000% Senior Notes due 2022, Cigna Corporation’s 4.000% Senior Notes due 2022, Express Scripts Holding Company’s 3.900%

Vecna Technologies, a leading provider of healthcare information technologies, announced today it has been awarded a contract to integrate its Patient Self-Service platform with Cerner, the VA’s new electronic health record system.

Centene Corporation (NYSE: CNC) announced today that its subsidiary Centurion has received notice from the Delaware Department of Correction of the Department’s intent to award two contracts to Centurion for medical and behavioral health services.

The Vilcek Foundation has issued an open call for applications for the 2021 Vilcek Prizes for Creative Promise in Biomedical Science

A well-known market intelligence company, Infiniti Research, has partnered with several top pharma companies to support their new drug development and launch processes and help implement seamless route-to-market strategies through turnkey solutions.

Medidata, the global leader in creating end-to-end solutions to support the entire clinical trial process, and a Dassault Systèmes company, announced that Medpace Inc. has entered into an agreement to integrate Medidata Rave Imaging with Medpace’s imaging systems and workflow.